|Based on abc biopply’s proprietary 3D CoSeedis™ technology, our CRO services ensure optimal preclinical results.
Through the unique design of 3D CoSeedis™ abc biopply’s assay are developed in-house, custom tailored and profit from:
- Physiological microenvironment that mimic in vivo conditions
- Native spheroid density comparable to tissue from patients
- Self-organised cell layering mimicking the situation observed in vivo (e.g. 3D micro-tumours vs. patient derived tumour tissue)